Log In
BCIQ
Print this Print this
 

VLT-002

  Manage Alerts
Collapse Summary General Information
Company Valentia Biopharma S.L.
DescriptionSmall molecule with anti DM1 activity
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMyotonic dystrophy type 1 (DM1)
Indication DetailsTreat myotonic dystrophy type 1 (DM1)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today